The turnover of basic pharmaceutical products and pharmaceutical preparations in Finland has shown a general upward trend from 2014 to 2023. The value was 1.86 billion euros in 2014 and reached 2.61 billion euros in 2023, marking significant growth. The period from 2016 to 2017 saw robust increases with year-on-year variations of 7.5% and 5.1% respectively. However, growth rates began to moderate, particularly between 2018 to 2023, averaging around 2.59% CAGR over the past five years. In 2023, the turnover stood at 2.61 billion euros, with a year-on-year increase of 2.91%.

Future trends to watch for include:

Continued moderate growth with a forecasted 5-year CAGR of 2.01% from 2024 to 2028 and an overall forecasted growth rate of 10.44% over the same period.
Potential impact of advancements in pharmaceutical technology and aging population increasing demand for medical products.
Regulatory dynamics and healthcare policy changes within the EU which could influence market conditions.